Health ❯ Pharmaceuticals ❯ Drug Approval

FDA

Clinical Trials Leucovorin Public Health Nonaddictive Pain Medication Market Reaction Inluriyo UZEDY (risperidone) Expedited Reviews Fast-Track Programs Leadership Issues Donanemab Ethics Kisunla

FDA Opens Safety Review of Infant RSV Antibody Drugs Beyfortus and Enflonsia

The agency says any label changes will occur only if a full review supports a safety concern.

FDA Fast-Tracks Augmentin XR in First Approval Under National Priority Voucher Pilot

Yale Study Finds Only 24% of Medicines Tested Reach Trial-Host Countries Within Five Years

FDA Drug-Review Chief George Tidmarsh Resigns as HHS Probes Conduct

FDA Names First 9 Drugs for ‘National Priority’ Fast-Track Reviews, Targeting 1–2-Month Decisions

FDA Clears Monthly Uzedy Injection for Maintenance Treatment of Bipolar I Disorder

Lilly Steps Up Obesity Push With San Diego Innovation Hub and $6.5 Billion Houston Factory

FDA Moves to List Leucovorin for Cerebral Folate Deficiency After White House Autism Promotion